Back to matchesWe found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleA phase II study of Mirvetuximab Soravtansine in triple-negative breast cancer.AuthorsYam, Clinton; Rauch, Gaiane M.; Rahman, Tanbin; Karuturi, Meghan; Ravenberg, Elizabeth; White, Jason; Clayborn, Alyson; McCarthy, Pamela; Abouharb, Sausan; Lim, Bora; Litton, Jennifer K.; Ramirez, David L.; Saleem, Sadia; Stec, James; Symmans, W. Fraser; Huo, Lei; Damodaran, Senthil; Sun, Ryan; Moulder, Stacy L.PublicationInvestigational New Drugs, 2021, Vol 39, Issue 2, p509ISSN0167-6997Publication typeArticleDOI10.1007/s10637-020-00995-2